(Q40550732)

English

Carbapenems

scientific article published on July 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

Carbapenems (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

carbapenem antibiotic

0 references

author name string

Norrby SR

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 July 1995

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Medical Clinics of North America

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

745-759

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

The pharmacokinetics of meropenem in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of meropenem in subjects with various degrees of renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An overview of the pharmacology of imipenem/cilastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple-dose pharmacokinetics of imipenem-cilastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thienamycin: development of imipenem-cilastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of meropenem, against gram-positive bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of imipenem in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Disposition of radiolabeled imipenem and cilastatin in normal human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Meropenem: evidence of lack of proconvulsive tendency in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative neurotoxicity of benzylpenicillin, imipenem/cilastatin and FCE 22101, a new injectible penem

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurotoxicity of β-lactam antibiotics: predisposing factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Imipenem/cilastatin in the treatment of obstetric and gynecologic infections: a review of worldwide experience

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety evaluation of meropenem in animals: studies on the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacokinetics and tissue penetration of imipenem

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Imipenem/cilastatin treatment of bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930037-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0025-7125(16)30037-2

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40550732&oldid=1900268824"